Distribution of surface-exposed antigenic glycolipids in recent clinical isolates off Mycobacterium tuberculosis

被引:13
|
作者
Munoz, M
Luquin, M
GarciaBarcelo, M
Julian, E
Ausina, V
Laneelle, MA
机构
[1] UNIV AUTONOMA BARCELONA,FAC CIENCIAS,UNIDAD MICROBIOL,DEPT GENET & MICROBIOL,BELLATERRA 08193,BARCELONA,SPAIN
[2] HOSP UNIV GERMANS TRIAS & PUJOL,MICROBIOL SERV,BADALONA 08916,BARCELONA,SPAIN
[3] UNIV TOULOUSE 3,CNRS,INST PHARMACOL & BIOL STRUCT,F-31062 TOULOUSE,FRANCE
关键词
antigenicity; glycolipid; Mycobacterium tuberculosis; chromatographic and chemical characterization; serodiagnosis;
D O I
10.1016/S0923-2508(97)83871-5
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The distribution of surface-exposed antigenic glycolipids in seven recent clinical isolates of Mycobacterium tuberculosis was established. Thin-layer and liquid chromatographies revealed a uniformity in the glycolipid pattern. Chemical analysis of the individual glycolipids of a selected strain enabled the identification of glycolipids of serological interest in all the other clinical isolates. Phenolic glycolipid-Tb1 (PGL-Tb1) was lacking in all strains, but appreciable amounts of;a partially deglycosylated version (PGL-Tb1D) were present in the seven isolates, Diacyltrehaloses (DATs) were detected in all strains, showing themselves to be major glycolipids, Lipooligosaccharides (LOS-II) were present in the seven strains studied though only in trace amounts, These results shed new light on the open debate on the distribution of these interesting glycolipids in typical clinical isolates of M. tuberculosis. In the search for a serological test for tuberculosis, and in accordance with our observations, we believe that PGL-Tb1 and LOS-II should not be the target molecules for serology and that it is worthwhile to continue investigating the value of DATs as antigens, We also believe that it would be of interest to undertake research to assess the usefulness of PGL-Tb1D as an antigen.
引用
收藏
页码:405 / 412
页数:8
相关论文
共 50 条
  • [41] An open-access dashboard to interrogate the genetic diversity of Mycobacterium tuberculosis clinical isolates
    Phelan, Jody
    van den Heede, Klaas
    Masyn, Serge
    Verbeeck, Rudi
    Lamprecht, Dirk A.
    Koul, Anil
    Wall, Richard J.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] Drug resistance in Mycobacterium tuberculosis clinical isolates from Brazil: Phenotypic and genotypic methods
    Miyata, Marcelo
    Pavan, Fernando Rogerio
    Sato, Daisy Nakamura
    Marino, Leonardo Biancolino
    Hirata, Mario Hiroyuki
    Cardoso, Rosilene Fressati
    Fiuza de Melo, Fernando Augusto
    Zanelli, Cleslei Fernando
    Fujimura Leite, Clarice Queico
    BIOMEDICINE & PHARMACOTHERAPY, 2011, 65 (06) : 456 - 459
  • [43] Genotyping of clinical Mycobacterium tuberculosis isolates based on eight loci of MIRU-VNTR
    Liu, R. X.
    Li, Q. Z.
    Xing, L. L.
    Peng, Z.
    Zhu, C. M.
    Yang, Z. H.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2013, 17 (02) : 243 - 245
  • [44] In vitro activity of antimicrobial combinations against clinical isolates of susceptible and resistant Mycobacterium tuberculosis
    Bergmann, JS
    Woods, GL
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1998, 2 (08) : 621 - 626
  • [45] Phylogenetic assignment of Mycobacterium tuberculosis Beijing clinical isolates in Japan by maximum a posteriori estimation
    Seto, Junji
    Wada, Takayuki
    Iwamoto, Tomotada
    Tamaru, Aki
    Maeda, Shinji
    Yamamoto, Kaori
    Hase, Atsushi
    Murakami, Koichi
    Maeda, Eriko
    Oishi, Akira
    Migita, Yuji
    Yamamoto, Taro
    Ahiko, Tadayuki
    INFECTION GENETICS AND EVOLUTION, 2015, 35 : 82 - 88
  • [46] Variation of the expression of Mycobacterium tuberculosis ppe44 gene among clinical isolates
    Rindi, Laura
    Peroni, Irene
    Lari, Nicoletta
    Bonanni, Daniela
    Tortoli, Enrico
    Garzelli, Carlo
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2007, 51 (02): : 381 - 387
  • [47] Linezolid resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Iran
    Khosravi, Azar Dokht
    Tabandeh, Mohammad Reza
    Shahi, Fatemeh
    Salmanzadeh, Shokrollah
    ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA, 2021, 68 (03) : 203 - 207
  • [48] Dideoxy fingerprinting for rapid screening of rpoB gene mutations in clinical isolates of Mycobacterium tuberculosis
    Liu, YC
    Huang, TS
    Huang, WK
    Chen, CS
    Tu, HZ
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1998, 97 (06) : 400 - 404
  • [49] GYRA AND GYRB MUTATIONS IN OFLOXACIN-RESISTANT MYCOBACTERIUM TUBERCULOSIS CLINICAL ISOLATES IN THAILAND
    Pitaksajjakul, Pannamthip
    Worakhunpiset, Suwalee
    Chaiprasert, Angkana
    Boonyasopun, Jirakarn
    Ramasoota, Pongrama
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 42 (05) : 1163 - 1167
  • [50] Preservation of clinical isolates of Mycobacterium tuberculosis complex directly from MGIT culture tubes
    Huang, TS
    Chen, YS
    Lee, SSJ
    Tu, HZ
    Liu, YC
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2005, 35 (04): : 455 - 458